• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$48.48 $0.44 (0.92%)

REAL-TIME: Last trade at

Valeant Pharmaceuticals Intern...

NYSE:VRX

Jump to this page for:

Related Resources

Biotech Hedge Fund Bought This Surging Stock, And Other 13D/G Filings Last Week

5/27/2012 by Seeking Alpha

Insiders Buying Shares In These 3 High-Growth Drug Stocks, Plus 2 Other Noteworthy Sells

5/25/2012 by Seeking Alpha

Vanguard Made Major Buys In These High Growth Healthcare And Tech Stocks In Q1

5/24/2012 by Seeking Alpha

Weekly Top Insider Buys: IBM, BAC, SPG, HES, VRX

5/21/2012 by Nasdaq

Applications Given Early Antitrust Clearance

5/21/2012 by Smart Money

You're Not the Only One Buying Here

5/15/2012 by DailyFinance

Valeant Pharmaceuticals International Beats on Both Top and Bottom Lines

5/7/2012 by DailyFinance

Valeant Boosts Full-Year Guidance, Buys Skincare Product Assets

5/3/2012 by Smart Money

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

4/26/2012 by Smart Money

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

4/25/2012 by Smart Money

Valeant Moving Global Headquarters To Province Of Quebec

4/3/2012 by Smart Money

Bausch + Lomb Nabs ISTA (ISTA, VRX)

3/27/2012 by 247wallst

Third Time's the Charm for This Small-Cap Buyout

3/27/2012 by DailyFinance

Valeant To Buy Russian Specialty Pharma Company For $180 Million

3/26/2012 by Smart Money

Canadian Shares Gain After Fed Chairman Signals Monetary Policy to Remain Accommodative

3/26/2012 by Nasdaq

Bausch + Lomb To Acquire ISTA In Cash Deal

3/26/2012 by Smart Money

Valeant To Buy Branded Generics Assets From Gerot Lannach

3/13/2012 by Smart Money

The Surprising Signal That Provides "Superior Information to Investors"

3/12/2012 by DailyFinance

Is Valeant Pharmaceuticals International Heading for a Slowdown?

3/8/2012 by DailyFinance

Valeant Pharmaceuticals International Beats Up on Analysts Yet Again

2/28/2012 by DailyFinance

Valeant Pharma Withdraws Bid For Drug-Maker ISTA Pharma

1/30/2012 by Smart Money

UPDATE: Valeant Pharma Withdraws Bid For ISTA Pharma

1/30/2012 by Smart Money

Profiting From Stock Buybacks

1/22/2012 by Smart Money

The Stock Making Buffett’s Pals at the Sequoia Fund Rich: Valeant Pharmaceuticals

1/20/2012 by YCharts

Buffett’s Pals at Sequoia Fund Own Less Berkshire, But Find Plenty of Winning Stocks

1/19/2012 by YCharts

Valeant Pharma Sees 2012 Earnings Above Street Estimates

1/6/2012 by Smart Money

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

12/19/2011 by Smart Money

5 of Last Week's Biggest Winners

12/19/2011 by DailyFinance

3 Stocks Shaking the Market

12/19/2011 by DailyFinance

This Week's Top Stock Gainers

12/17/2011 by DailyFinance

UPDATE: Valeant Makes Public Its Interest In Buying ISTA

12/16/2011 by Smart Money

2nd UPDATE: ISTA Rejects Valeant's $314 Million Takeover Offer

12/16/2011 by Smart Money

Mid-Day Update: Stocks Firm as Inflation Appears in Check; Zynga Begins Trading

12/16/2011 by Nasdaq

CORRECT(12/13): FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment

12/15/2011 by Smart Money

FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment

12/13/2011 by Smart Money

Applications Given Early Antitrust Clearance

12/12/2011 by Smart Money

FTC Orders Valeant To Sell 3 Drugs To Acquire Dermatology Businesses

12/12/2011 by Smart Money

Checking an Important, Overlooked Metric at Abbott Labs

11/16/2011 by DailyFinance

Abbott Laboratories Passes This Key Test

11/15/2011 by DailyFinance

This Just In: Upgrades and Downgrades

10/25/2011 by DailyFinance
See More Articles...